For the study, researchers tracked 1,070 kids aged 12 to 18 who were overweight or obese and also had a diagnosis of asthma.

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to patients in ...

SaveHealth reports seven asthma medication categories, including inhaled corticosteroids and biologics, helping manage ...

The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an eosinophilic phenotype, according to a press release from GSK.Depemokimab ...

Medically reviewed by Daniel More, MD Key Takeaways Asthma action plans help maintain good asthma control by outlining ...

Misunderstanding COPD and asthma can be risky. Recognising the difference in the condition, treatment options, and the need ...

Diagnosing precisely what type of asthma a child has and fine-tuning the treatment for it involves an invasive procedure under general anesthesia. For children with mild asthma, it's just not worth ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

What can you do to help your eosinophilic asthma treatments work their best? There are simple steps you can take each day to improve symptoms, quality of life, and overall health. Eosinophilic asthma ...

As the prevalence of asthma continues to increase, the financial impact on the healthcare costs of the United States does as well. Managed care pharmacists are ideally situated to unite the shared ...

This year’s top asthma and respiratory disorder story focused on the pushback from multiple advocacy groups following ...